C-Reactive protein predicts short-term mortality in patients with cirrhosis

Journal of Hepatology

Volumn 56, Issue 6, 2012, Pages 1299-1304

  Cervoni, Jean Paul ^a   Thévenot, Thierry ^a   Weil, Delphine ^a   Muel, Emilie ^a   Barbot, Olivier ^a   Sheppard, Frances ^b   Monnet, Elisabeth ^a   Di Martino, Vincent ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

95 CI; 95 confidence interval; ACCP SCCM; acute physiology and chronic health evaluation; Akt; American College of Chest Physicians Society of Critical Care Medicine; analysis of variance; ANOVA; APACHE; area under the receiver operating characteristic curve; AUROC; C reactive protein; computed tomography; CRP; CT; Hazard ratio; HCC; hepatocellular carcinoma; HR; IL6; INR; interleukin 6; International Normalized ratio; MELD; Model of End Stage Liver Disease; Na; natremia; negative predictive value; NPV; positive predictive value; PPV; proteine kinase B; SE; sequential organ failure assessment; SIRS; SOFA; standard error; systemic inflammatory response syndrome; ultrasonography; US

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; BACTERIAL INFECTION; COMORBIDITY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEPATORENAL SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LACTATE BLOOD LEVEL; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SEVERITY OF ILLNESS INDEX; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84861182276     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.12.030     Document Type: Article

References (29)

1. C. Vanlemmens, V. Di Martino, C. Milan, M. Messner, A. Minello, and C. Duvoux Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis: a randomized trial Ann Intern Med 150 2009 153 161
2. R. Malik, R.P. Mookerjee, and R. Jalan Infection and inflammation in liver failure: two sides of the same coin J Hepatol 51 2009 426 429
3. J.A. Leithead, J.W. Ferguson, C.M. Bates, J.S. Davidson, A. Lee, and A.J. Bathgate The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure Gut 58 2009 443 449
4. N. Rolando, J. Wade, M. Davalos, J. Wendon, J. Philpott-Howard, and R. Williams The systemic inflammatory response syndrome in acute liver failure Hepatology 32 2000 734 739
5. J. Vaquero, J. Polson, C. Chung, I. Helenowski, F.V. Schiodt, and J. Reisch Infection and the progression of hepatic encephalopathy in acute liver failure Gastroenterology 125 2003 755 764 (Pubitemid 37070693)
6. D.L. Shawcross, N.A. Davies, R. Williams, and R. Jalan Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis J Hepatol 40 2004 247 254 (Pubitemid 38115829)
7. M. Cazzaniga, E. Dionigi, G. Gobbo, A. Fioretti, V. Monti, and F. Salerno The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome J Hepatol 51 2009 475 482
8. D. Thabut, J. Massard, A. Gangloff, N. Carbonell, C. Francoz, and E. Nguyen-Khac Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure Hepatology 46 2007 1872 1882
9. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
10. G.P. Castelli, C. Pognani, M. Meisner, A. Stuani, D. Bellomi, and L. Sgarbi Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction Crit Care 8 2004 R234 R242
11. P. Chauveau, C. Level, C. Lasseur, H. Bonarek, E. Peuchant, and D. Montaudon C-reactive protein and procalcitonin as markers of mortality in hemodialysis patients: a 2-year prospective study J Ren Nutr 13 2003 137 143 (Pubitemid 38368772)
12. A. Lavrentieva, T. Kontakiotis, L. Lazaridis, N. Tsotsolis, J. Koumis, and G. Kyriazis Inflammatory markers in patients with severe burn injury. What is the best indicator of sepsis? Burns 33 2007 189 194 (Pubitemid 46201864)
13. C. Wanner, and T. Metzger C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients Nephrol Dial Transplant 17 2002 29 32 [discussion 9-40] (Pubitemid 34918876)
14. W.B. Park, K.D. Lee, C.S. Lee, H.C. Jang, H.B. Kim, and H.S. Lee Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis Diagn Microbiol Infect Dis 51 2005 227 230 (Pubitemid 40460957)
15. D.P. Bota, M. Van Nuffelen, A.N. Zakariah, and J.L. Vincent Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver J Lab Clin Med 146 2005 347 351 (Pubitemid 41712021)
16. M. Charlson, T.P. Szatrowski, J. Peterson, and J. Gold Validation of a combined co-morbidity index J Clin Epidemiol 47 1994 1245 1251
17. A.J. Rosenbloom, M.R. Pinsky, J.L. Bryant, A. Shin, T. Tran, and T. Whiteside Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. Correlation with serum interleukin-6 levels and organ dysfunction JAMA 274 1995 58 65
18. A. Albillos, A. de la Hera, M. Gonzalez, J.L. Moya, J.L. Calleja, and J. Monserrat Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement Hepatology 37 2003 208 217 (Pubitemid 36042162)
19. K. Heikkila, S. Ebrahim, A. Rumley, G. Lowe, and D.A. Lawlor Associations of circulating C-reactive protein and interleukin-6 with survival in women with and without cancer: findings from the British Women's Heart and Health Study Cancer Epidemiol Biomarkers Prev 16 2007 1155 1159 (Pubitemid 46984952)
20. I. Cirera, T.M. Bauer, M. Navasa, J. Vila, L. Grande, and P. Taura Bacterial translocation of enteric organisms in patients with cirrhosis J Hepatol 34 2001 32 37
21. M. Perez-Paramo, J. Munoz, A. Albillos, I. Freile, F. Portero, and M. Santos Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites Hepatology 31 2000 43 48 (Pubitemid 30033687)
22. T. Thevenot, J.P. Cervoni, E. Monnet, F. Sheppard, and V.D. Martino Is this really the end of beta-blockers in patients with cirrhosis and refractory ascites? Hepatology 53 2011 715 716
23. N. Coant, M. Simon-Rudler, T. Gustot, M. Fasseu, S. Gandoura, and K. Ragot Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis J Hepatol 55 2011 784 793
24. V. Arvaniti, G. D'Amico, G. Fede, P. Manousou, E. Tsochatzis, and M. Pleguezuelo Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis Gastroenterology 139 2010 1246 1256 56 e1-5
25. R. Jalan, and R. Mookerjee Systemic hemodynamic, hepatic blood flow and portal pressure in patients with cirrhosis and multiorgan failure: the role of sympathetic activation Hepatology 48 2008 1077A
26. R.P. Mookerjee, M. Malaki, N.A. Davies, S.J. Hodges, R.N. Dalton, and C. Turner Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis Hepatology 45 2007 62 71 (Pubitemid 46144365)
27. R. Jalan, K. Schnurr, R.P. Mookerjee, S. Sen, L. Cheshire, and S. Hodges Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality Hepatology 50 2009 555 564
28. G. Fernandez-Esparrach, A. Sanchez-Fueyo, P. Gines, J. Uriz, L. Quinto, and P.J. Ventura A prognostic model for predicting survival in cirrhosis with ascites J Hepatol 34 2001 46 52 (Pubitemid 32102551)
29. W.R. Kim, S.W. Biggins, W.K. Kremers, R.H. Wiesner, P.S. Kamath, and J.T. Benson Hyponatremia and mortality among patients on the liver-transplant waiting list N Engl J Med 359 2008 1018 1026